GlassScriptPhysician profile
Allen C Rassa
NPI 1932465424
$14,858.06
in general payments reported to CMS, 2019-2025
23 companies · $1,480 in 2025
The $1,480 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,735 · 2020: $118 · 2021: $51.53 · 2022: $419 · 2023: $10K · 2024: $890 · 2025: $1,480.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $6,600 · Food and Beverage: $3,692 · Travel and Lodging: $2,242.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $6,600.00 |
| Food and Beverage | $3,692.08 |
| Travel and Lodging | $2,241.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shockwave Medical, INC | $8,608.93 | 2023-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Medtronic Vascular, INC. | $1,604.12 | 2019 | |
| Boston Scientific Corporation | $979.48 | 2023-2025 | Watchman Access System |
| E.R. Squibb & Sons, L.L.C. | $570.21 | 2023-2025 | Camzyos, Eliquis |
| Medtronic, INC. | $560.97 | 2022-2025 | Symplicity G3, Avalus |
| Boehringer Ingelheim Pharmaceuticals, INC. | $450.30 | 2019-2025 | Jardiance |
| Penumbra, INC. | $262.09 | 2020-2024 | Indigo System, Penumbra System |
| Kaneka Medical America LLC | $246.01 | 2025 | Apheresis Machine |
| Inari Medical, INC. | $241.95 | 2023-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Abbott Laboratories | $237.58 | 2025 | Coroflow, Diamondback Coronary |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $223.36 | 2023-2025 | Lifevest |
| Novartis Pharmaceuticals Corporation | $192.97 | 2023-2025 | |
| Abiomed | $185.67 | 2020-2025 | |
| Bridgebio Pharma, INC. | $123.21 | 2025 | Attruby |
| Kestra Medical Technology Services, INC. | $95.12 | 2023-2024 | Assure Wcd |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cardiovascular Systems INC. | $79.81 | 2022-2023 | Diamondback Coronary |
| Teleflex LLC | $55.18 | 2025 | Supercross, Guideliner |
| Heartflow, INC. | $54.67 | 2023 | Ffrct |
| Circa Scientific, INC. | $23.55 | 2025 | |
| Pfizer INC. | $17.85 | 2023 | |
| Merck Sharp & Dohme LLC | $16.16 | 2022 | |
| Biotronik INC. | $15.35 | 2021 | |
| Scpharmaceuticals INC. | $13.52 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Allen Rassa listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.